From: Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
Group | Treatment | PCNA-labeling | Apoptotic | Scores for: | |||
---|---|---|---|---|---|---|---|
no. |  | index (%) | index (%) | β-Catenin | COX-2 | iNOS | Nitrotyrosine |
1 | AOM/DSS | 62.4 ± 13.7a (30) | 4.1 ± 1.9 (30) | 3.7 ± 0.7 (30) | 3.3 ± 0.7 (30) | 3.0 ± 1.0 (30) | 3.1 ± 0.8 (30) |
2 | AOM/DSS/0.04% Nimesulide | 38.3 ± 11.1 b (6) | 11.8 ± 2.9 b (6) | 2.3 ± 1.0 c (6) | 1.3 ± 0.5 b (6) | 1.3 ± 0.5 b (6) | 1.7 ± 0.5 b (6) |
3 | AOM/DSS/0.05% Troglitazone | 43.6 ± 9.0 b (9) | 10.0 ± 2.4 b (9) | 2.7 ± 0.7 c (9) | 1.8 ± 0.8 b (9) | 1.6 ± 0.5 b (9) | 1.8 ± 0.6 b (9) |
4 | AOM/DSS/0.05% Bezafibrate | 40.5 ± 12.7 b (15) | 9.7 ± 2.7 b (15) | 3.0 ± 0.8 (15) | 1.8 ± 0.8 b (15) | 1.6 ± 0.6 b (15) | 2.2 ± 1.1 b (15) |